Blood and Urine Study During Radiation Therapy
Part of Cancer clinical trials.
This study collects blood and urine samples from patients receiving radiation therapy to understand how the body responds to treatment. It may help researchers improve radiation therapy in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be enrolled in another National Institutes of Health (NIH) study at their Clinical Center that includes radiation therapy
- You are receiving or are scheduled to receive radiation therapy
- You are 18 years old or older
- You can understand the study and sign a consent form (or have a legally authorized representative do so)
- Your medical records about any previous radiation therapy must be available
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a protein called CHI3L1 in your blood can help predict how well tumors will respond to radiation therapy. It is open to people with several types of cancer who are in good overall health.
This study looks for a new set of urine “markers” (measurable substances in urine) that may help detect cancer earlier. If you join, they will collect your urine and compare results between people with cancer and people without cancer.
This study looks at how a tumor’s immune system responds when you receive radiotherapy. It involves taking a planned pre-treatment biopsy so researchers can study immune and tumor changes and see if radiotherapy affects them.
This study collects blood and urine samples from patients receiving radiation treatment for glioblastoma (a serious brain tumor) to help researchers understand how the body responds to radiation therapy. Participating is straightforward—you provide samples during your regular treatment.
This study builds a registry and blood/tissue sample collection for people who have cancer or a non-cancer growth (benign tumor) and are receiving radiation. It helps researchers learn from real-world treatment and biology, which may improve future care.
This study collects blood and tissue samples from people with cancer or suspected cancer, or from their blood relatives. Researchers use these samples to better understand cancer and develop new treatments.
Hear when a new Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.